The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $94.30

Today's change+0.83 +0.89%
Updated March 23 4:02 PM EDT. Delayed by at least 15 minutes.
 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $94.30

Today's change+0.83 +0.89%
Updated March 23 4:02 PM EDT. Delayed by at least 15 minutes.

Edwards Lifesciences Corp crosses above 50-day moving average

Edwards Lifesciences Corp closed up Thursday by (U.S.)$0.83 or 0.89% to (U.S.)$94.30 and crossing above its 50-day moving average. Over the last five days, shares have gained 1.45%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 5.39% during the last year.

Key company metrics

  • Open(U.S.) $93.47
  • Previous close(U.S.) $93.47
  • High(U.S.) $95.32
  • Low(U.S.) $93.22
  • Bid / Ask(U.S.) $89.00 / (U.S.) $95.70
  • YTD % change+0.64%
  • Volume1,666,855
  • Average volume (10-day)2,065,979
  • Average volume (1-month)2,389,636
  • Average volume (3-month)2,389,187
  • 52-week range(U.S.) $81.12 to (U.S.) $121.75
  • Beta0.62
  • Trailing P/E36.07×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.61
Updated March 23 4:02 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.55%Sector:HealthcareIndustry:Advanced Medical Equipment

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue768739759697
Total other revenue--------
Total revenue768739759697
Gross profit555538557517
Total cost of revenue213201203180
Total operating expense567554590514
Selling / general / administrative234230229213
Research & development115113113102
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)574412
Other operating expenses, total1395
Operating income200185169183
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax200185169183
Income after tax159141127143
Income tax, total42444240
Net income159141127143
Total adjustments to net income--------
Net income before extra. items159141127143
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items159141127143
Inc. avail. to common incl. extra. items159141127143
Diluted net income159141127143
Dilution adjustment--0--0
Diluted weighted average shares218218217218
Diluted EPS excluding extraordinary itemsvalue per share0.730.650.580.66
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.740.670.730.70